Pacira BioSciences, Inc. (PCRX)
NASDAQ: PCRX · Real-Time Price · USD
22.88
-0.43 (-1.84%)
At close: Mar 27, 2026, 4:00 PM EDT
22.44
-0.44 (-1.92%)
After-hours: Mar 27, 2026, 5:30 PM EDT

Pacira BioSciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
9261,1138711,5681,7732,692
Market Cap Growth
-11.77%27.80%-44.45%-11.56%-34.12%3.08%
Enterprise Value
1,1061,327594.41,4151,6692,106
Last Close Price
22.8825.8818.8433.7438.6160.17
PE Ratio
144.96161.75-8.7637.91113.5665.40
Forward PE
8.657.537.1010.2311.6415.43
PEG Ratio
-0.660.660.660.660.66
PS Ratio
1.281.531.242.322.664.97
P/FCF Ratio
6.78-4.8711.2415.3933.71
P/OCF Ratio
6.10-4.6010.1412.2121.41
EV/Sales Ratio
1.521.830.852.102.503.89
EV/EBITDA Ratio
8.9069.15109.798.6711.0217.78
EV/EBIT Ratio
33.2269.15-8.1016.1427.8123.42
EV/FCF Ratio
8.09-3.3310.1414.4926.38
Debt / EBITDA Ratio
19.3919.39----
Net Debt / EBITDA Ratio
11.1311.13-51.12-0.94-0.69-4.94
Net Debt / FCF Ratio
---1.55-1.10-0.90-7.33
Asset Turnover
3.343.343.265.241.931.58
Return on Assets (ROA)
3.68%3.68%-53.83%46.32%20.82%19.53%
Return on Capital Employed (ROCE)
8.82%8.82%-34.12%68.11%17.41%26.23%
Earnings Yield
0.76%0.62%-11.41%2.64%0.88%1.53%
FCF Yield
14.75%0.00%20.52%8.89%6.50%2.97%
Buyback Yield / Dilution
2.60%2.60%11.03%-11.69%-1.99%-4.46%
Total Shareholder Return
2.60%2.60%11.03%-11.69%-1.99%-4.46%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q